Cost-effectiveness of Add-On Ivabradine Versus Standard Pharmacotherapy in the Treatment of Heart Failure in Vietnam: An Analysis From a Health System Perspective

From a Vietnamese health system perspective, adding ivabradine to standard pharmacotherapy is likely to be a cost-effective strategy for treating eligible patients with HF. This evidence supports value-based pricing in price negotiations and efficient resource use.